Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

57.15
Delayed Data
As of 12:47pm ET
 +0.15 / +0.26%
Today’s Change
26.80
Today|||52-Week Range
73.54
+26.65%
Year-to-Date
Esperion (ESPR) Offers Updates on LDL-Lowering Candidate
11:54am / Zacks.com - Paid Partner Content
Pluristem Therapeutics (PSTI) Catches Eye: Stock Up 11.6%
Jun 23 / Zacks.com - Paid Partner Content
Endo's Stock Gains on Vasostrict's New Patent Approval
11:21am / Zacks.com - Paid Partner Content
Prima Reports Favorable Initial Breast Cancer Study Data
Jun 22 / Zacks.com - Paid Partner Content
Two Small-Cap Healthcare Stocks That are Cheap Buys Right Now
12:51am / Zacks.com - Paid Partner Content
GW Pharma (GWPH) to Develop Epidiolex for Infantile Spasms
Jun 22 / Zacks.com - Paid Partner Content
The Medicines Co.'s Carbavance Scores in Phase III Study
Jun 28 / Zacks.com - Paid Partner Content
RedHill (RDHL) Stock Up on Positive Phase I Data on Yeliva
Jun 22 / Zacks.com - Paid Partner Content
GW Pharmaceuticals Stock Up on Positive Epidiolex Data
Jun 28 / Zacks.com - Paid Partner Content
Inovio Stock Up, Zika Vaccine Gets Nod for Phase I Study
Jun 21 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: John Bean Technologies, ANI Pharmaceuticals, Clearwate...
Jun 27 / Zacks.com - Paid Partner Content
Fate's (FATE) ProTmune Gets Fast Track Status, Stock Up
Jun 21 / Zacks.com - Paid Partner Content
Sanofi Inks Deal to Swap Business with Boehringer Ingelheim
Jun 27 / Zacks.com - Paid Partner Content
Gilead Presents Favorable Preliminary Bictegravir HIV Data
Jun 21 / Zacks.com - Paid Partner Content
XBiotech (XBIT) Catches Eye: Stock Adds 5.6% in Session
Jun 27 / Zacks.com - Paid Partner Content
Vical (VICL) Reports Phase I/II Data on Genital Herpes Vaccine
Jun 21 / Zacks.com - Paid Partner Content
Genmab/Novartis' Arzerra Gets Unfavorable CHMP Opinion
Jun 24 / Zacks.com - Paid Partner Content
Sunesis Pharmaceuticals (SNSS) in Focus: Stock Gains 8.7%
Jun 21 / Zacks.com - Paid Partner Content
Gilead's (GILD) HIV Treatment Odefsey Gains Approval in EU
Jun 24 / Zacks.com - Paid Partner Content
WAVE Life Sciences (WVE) in Focus: Stock Up 6.1% in Session
Jun 21 / Zacks.com - Paid Partner Content
5 Stocks to Buy on New Analyst Coverage
Jun 24 / Zacks.com - Paid Partner Content
GTx (GTXI) Shows Strength: Stock Adds 11.2% in Session
Jun 21 / Zacks.com - Paid Partner Content
Proteon Therapeutics (PRTO) in Focus: Stock Gains 6.4%
Jun 24 / Zacks.com - Paid Partner Content
Auris (EARS) Begins Phase III Study for Sudden Deafness
Jun 20 / Zacks.com - Paid Partner Content
Axsome Therapeutics (AXSM) Catches Eye: Stock Jumps 6.6%
Jun 24 / Zacks.com - Paid Partner Content
Emergent (EBS) BioThrax sBLA Accepted for FDA Review
Jun 20 / Zacks.com - Paid Partner Content
Cascadian Therapeutics (CASC) Jumps: Stock Rises 10.4%
Jun 24 / Zacks.com - Paid Partner Content
Medivation's (MDVN) Pidilizumab Positive in Phase I/II Study
Jun 17 / Zacks.com - Paid Partner Content
Retrophin (RTRX) RE-024 Positive in Physician-Initiated Study
Jun 24 / Zacks.com - Paid Partner Content
Idera Pharmaceuticals (IDRA) Catches Eye: Stock Rises 8.3%
Jun 17 / Zacks.com - Paid Partner Content
Anavex's Lead Candidate Gets Orphan Drug Status Yet Again
Jun 23 / Zacks.com - Paid Partner Content
Emergent (EBS) BioThrax Gets Orphan Status in the U.S.
Jun 16 / Zacks.com - Paid Partner Content
Incyte Reports Epacadostat Combination Study Initiation
Jun 23 / Zacks.com - Paid Partner Content
Endo's (ENDP) Pain Drug Opana ER to Face FDA Panel in Fall
Jun 16 / Zacks.com - Paid Partner Content
Nymox (NYMX) Stock Up on Positive 7-Year Fexapotide Data
Jun 23 / Zacks.com - Paid Partner Content
Cytokinetics (CYTK) Looks Good: Stock Adds 6.8% in Session
Jun 16 / Zacks.com - Paid Partner Content
Epizyme Teams Up with Roche's Genentech for Tazemetostat
Jun 23 / Zacks.com - Paid Partner Content
Jazz Pharmaceuticals Offers HAL Study Data on JZP-110
Jun 15 / Zacks.com - Paid Partner Content